Arca
Skip to content
Tools
Tools

Minder System

Sub-Scalp Implanted Electroencephalogram System For Remote Patient Monitoring. De Novo DEN240062, from Epi-Minder Pty, Ltd. (Melbourne, AU). Product code SEM, class 2.

As of Nov 21, 2026, DEN240062 is an FDA De Novo held by Epi-Minder Pty, Ltd., granted on Apr 17, 2025 after 181 days, with no recalls tied to it in FDA's recall database.

  • Review time: 181 days
  • Recalls: 0
  • Cited as a predicate by: 2 devices

Indications for use

As the 510(k) summary states them, read from FDA's summary PDF

“The Minder System is an electroencephalographic (EEG) recording and transmitting device implanted under the scalp. It is a prescription device indicated to acquire, transmit, and store EEGs continuously from patients between 18-75 years of age with drug-resistant epilepsy who are intolerant or not indicated for more conservative monitoring tools.

Pivotal study

The main clinical evidence FDA relied on, as its decision summary describes it
Design
Prospective, open-label, case-controlled comparator study at 6 OUS sites in Australia
Enrolled
31
Where
6 sites, Australia
Primary endpoint
Primary safety objective: adverse events (AEs) and serious adverse events (SAEs) from enrollment through study completion
Result
23 of 26 implanted subjects had an AE (128 AEs total); 8 subjects had an SAE (17 SAEs total). No pass/fail threshold stated.

Cited as a predicate

2 later 510(k) summaries name this device as a predicate

Other SEM clearances

The newest 510(k)s for the same product code; see every SEM device

Record

Type
Direct
Received
Oct 18, 2024
Review panel
Neurology
Regulation
21 CFR 882.1360

One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.